Celera Genomics and Celera Diagnostics to Webcast Presentation at First Analysis Investment Conference
ROCKVILLE, MD and ALAMEDA, CA - October 30, 2003
Celera Genomics Group (NYSE:CRA) and Celera Diagnostics, a joint venture of Celera Genomics and the third Applera business, Applied Biosystems Group (NYSE:ABI), will webcast a presentation at the First Analysis Investment Conference on Thursday, November 6, 2003. The webcast is scheduled to begin at 1:35 p.m. EST. Kathy Ordoņez, President of Celera Genomics and Celera Diagnostics, will discuss the therapeutic discovery and development programs of Celera Genomics and provide an update on molecular diagnostics discovery and development programs at Celera Diagnostics.
Interested parties may access the live webcast and replay by visiting the Investors & Media section of the Celera Genomics web site at www.celera.com or the Investors & Media section of the Applera web site at www.applera.com. It is suggested that participants access the webcast 15 minutes before the start of the live broadcast. The replay will be available through January 5, 2004.
About Applera Corporation
Applera Corporation consists of two operating groups. The Celera Genomics Group, located in Rockville, MD, and South San Francisco, CA, is engaged principally in integrating advanced technologies to discover and develop new therapeutics. Celera intends to leverage its proteomic, bioinformatic, and genomic capabilities to identify and validate drug targets, and to discover and develop new therapeutics. Its Celera Discovery SystemTM online platform, marketed exclusively through the Applied Biosystems Knowledge Business, is an integrated source of information based on the human genome and other biological and medical sources. The Applied Biosystems Group serves the life science industry and research community by developing and marketing instrument-based systems, consumables, software, and services. Customers use these tools to analyze nucleic acids (DNA and RNA), small molecules, and proteins to make scientific discoveries, develop new pharmaceuticals, and conduct standardized testing. Applied Biosystems is headquartered in Foster City, CA, and reported sales of $1.7 billion during fiscal 2003. Celera Diagnostics, a 50/50 joint venture between Applied Biosystems and Celera Genomics, is focused on discovery, development, and commercialization of novel diagnostic products. Information about Applera Corporation, including reports and other information filed by the company with the Securities and Exchange Commission, is available at www.applera.com, or by telephoning 800.762.6923. Information about Celera Genomics is available at www.celera.com.
Notice To Readers: Celera's press releases, presentations and printed remarks are included on this website for historical purposes only. The information contained in these documents should be considered accurate only as of the date of the relevant document. This information may change over time, and therefore visitors to this website should not assume that the information contained in these documents remains accurate at a later time. We do not have any current intention to update any of the information in these documents.